Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04SIU
|
||||
Former ID |
DIB004144
|
||||
Drug Name |
MCD-386
|
||||
Synonyms |
CDD-0102; CDD-0262; CDD-0264; CDD-102; MCD-386 Forte; MCD-386 Transderm; MCD-386CR; MCD-386 Forte/Transderm; Tetrahydropyrimidine muscarinic M1 agonists (Alzeimer's disease), Cognitive Pharmaceuticals; Tetrahydropyrimidine muscarinic M1 agonists (Alzeimer's disease), University of Toledo; Tetrahydropyrimidine muscarinicM1 agonists (Alzheimer's disease), Mithridion; MCD-386 (oral controlled release, CNS disorders), Mithridion; MCD-386 (high dose transdermal, Alzheimer's disease/schizophrenia), Mithridion; MCD-386 (high dose, Alzheimer's disease/schizophrenia), Mithridion; MCD-386 (transdermal, Alzheimer's disease/schizophrenia), Mithridion
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 1 | [546687] | ||
Company |
Mithridion Inc; University of Toledo
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
n1c(onc1CC)C1CN=CNC1
|
||||
CAS Number |
CAS 146422-58-4
|
||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M1 | Target Info | Agonist | [527660] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.